Understanding Pharma Market Access in the US

THE CONTENT
The US is the world’s largest pharmaceutical market and a critical driver of global brand success. Yet its highly fragmented healthcare system, dominated by a mix of public and private payers with different incentives and decision-making processes, makes market access uniquely complex.

For global and cross-functional teams, understanding these dynamics is critical to shaping effective pricing and access strategies. Recent policy developments — including the Inflation Reduction Act, the Pharmacy Benefit Manager Transparency Act, and Most Favoured Nation Pricing — are reshaping the landscape and must be factored into launch and market access planning.

This one-day course offers a clear and practical introduction to the fundamentals of US pharma market access. You will gain a solid understanding of the key players, systems, and drivers that shape access decisions, and learn how to anticipate challenges and navigate the most effective routes to success.

THE EXPERTS
Nick Proctor and Louisa Oliver Byrne are highly experienced consultants specialising in global market access strategy.